#Gulf Pharmaceutical Industries

Julphar posts Dhs859.4m in H1 revenues, up 2.5%

Julphar half-year revenues surge to Dhs859.4m on solid growth

The company registered double-digit growth in the UAE and GCC region markets due to continued positive developments in key markets including Saudi Arabia

UAE’s Julphar to launch over 100 new products as part of its Strategy 2030

Julphar will expand its presence into new territories, including CIS countries, Turkey, Latin America and Africa, to create new revenue streams

UAE’s Julphar reports net profit of Dhs63.9m in 2021

The pharma company announced it had seen top line growth and a return to a profitable bottom line compared to the previous year

Ras Al Khaimah pharma company Julphar launches Dhs500m rights issue

The new capital is also expected to help it expand operations in key markets in the region